Feed Preview

Fast Growing

Ebola Vaccine

Ebola Vaccine diagram by undefined

The recent ebola outbreak in west Africa has stressed the need for advances in research to develop a vaccine against this deadly virus. Much progress has been made in pre-clinical and clinical studies and future vaccines for the ebola virus look promising. Here is the latest research on ebola vaccines.

Top 20 most recent papers
The New England Journal of Medicine

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

The New England Journal of MedicineNovember 27, 2019
Sabue MulanguJacqueline Nordwall
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaNovember 30, 2019
Chris DavisEmma C Thomson
Intensive Care Medicine

Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative review

Intensive Care MedicineNovember 26, 2019
Laure F PittetDidier Pittet

Phenotypic size heterogeneity is a viral mechanism of persistence

bioRxivNovember 15, 2019
Tian LiTijana Ivanovic
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Perceived Benefits and Challenges of Ebola Preparation Among Hospitals in Developed Countries: A Systematic Literature Review

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaAugust 13, 2019
Mireia Puig-AsensioMarin L Schweizer

Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections

bioRxivDecember 2, 2019
Zhengchen SuBin Gong

SharpTNI: Counting and Sampling Parsimonious Transmission Networks under a Weak Bottleneck

bioRxivNovember 14, 2019
Palash Sashittal, Mohammed El-Kebir
Epidemiologic Reviews

Forecasting the 2014 West African Ebola Outbreak

Epidemiologic ReviewsNovember 29, 2019
Cristina CariasMartin Isaac Meltzer
The New England Journal of Medicine

Monoclonal Antibody Therapy for Ebola Virus Disease

The New England Journal of MedicineNovember 27, 2019
Myron M. Levine

Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators

MSphereDecember 4, 2019
Joseph B PrescottJonathan S Towner

Ebola Virus Uptake into Polarized Cells from the Apical Surface

VirusesDecember 2, 2019
Meng HuZong-Qiang Cui
Intensive Care Medicine Experimental

Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model

Intensive Care Medicine ExperimentalDecember 4, 2019
Guillaume PoliquinJames E Strong
Expert Review of Vaccines

Ebola Vaccine Trials: Progress in Vaccine Safety and Immunogenicity

Expert Review of VaccinesNovember 29, 2019
Keesha M MatzHeinz Feldmann
BMJ Global Health

Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980-2016

BMJ Global HealthOctober 18, 2019
Rose MbayeYap Boum Ii
International Journal of Environmental Research and Public Health

Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact

International Journal of Environmental Research and Public HealthNovember 21, 2019
Varvara A MouchtouriChristos Hadjichristodoulou
PLoS Neglected Tropical Diseases

Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels

PLoS Neglected Tropical DiseasesNovember 21, 2019
Gerardo ChowellMaria A Kiskowski
BMC Infectious Diseases

Assessment of a health facility based active case finding system for Ebola virus disease in Mbandaka, Democratic Republic of the Congo, June-July 2018

BMC Infectious DiseasesNovember 21, 2019
Amber KunkelMamoudou Harouna Djingarey
Seminars in Immunology

Global virus outbreaks: Interferons as 1st responders

Seminars in ImmunologyJune 1, 2019
Ben X Wang, Eleanor N Fish
Epidemiology and Health

Risk estimation of Ebola virus disease outbreak in the Republic of Korea: using mathematical model and stochastic simulation

Epidemiology and HealthNovember 24, 2019
Youngsuk KoEunok Jung
Disaster Medicine and Public Health Preparedness

Conference Report: Global Health Security Alliance (GLoHSA), a Product of the World Health Summit

Disaster Medicine and Public Health PreparednessNovember 29, 2019
John M QuinnRichard Sullivan

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2019 Meta ULC. All rights reserved